Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Financial Analyst Reaffirms Positive Outlook on Metropolitan Bank Holding with Revised Price Target

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
MO stock news
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

On March 4, 2024, financial analyst Alex Lau from JP Morgan reaffirmed his positive outlook on Metropolitan Bank Holding (NYSE: MCB) with an Overweight rating. However, he did revise the price target downward from $62 to $55. This decision was influenced by increasing regulatory scrutiny and the bank’s recent decision to discontinue its Banking as a Service (BaaS) offerings. Lau believes that these factors may impact the bank’s performance in the near future.

[bs_slider_forecast ticker=”MCB”]

MCB Stock Price Declines on March 4, 2024: Analysis and Insights

On March 4, 2024, MCB stock experienced a decline in its price performance. According to data from CNN Money, MCB is currently trading in the middle of its 52-week range and below its 200-day simple moving average. This indicates that the stock may be facing some challenges in terms of its overall trend and momentum.

The price of MCB shares dropped by $1.21 since the market last closed, representing a 3.09% decrease. The stock closed at $38.00, which is lower than its previous closing price. Despite this drop, the stock remained unchanged in after-hours trading, suggesting that there may be some stability or support at the current price level.

Currently Playing

MCB Stock Shows Impressive Growth in Total Revenue, Net Income, and EPS in 2024

On March 4, 2024, MCB stock showed impressive performance with total revenue reaching $403.31 million over the past year, representing a 40.36% increase compared to the previous year. However, the total revenue remained flat since the last quarter at $111.76 million.

Similarly, the net income for MCB stood at $76.90 million over the past year, showing a 29.72% increase compared to the previous year. The net income also remained flat since the last quarter at $14.49 million.

Earnings per share (EPS) for MCB were reported at $6.91 over the past year, reflecting a 30.54% increase compared to the previous year. The EPS also remained flat since the last quarter at $1.27.

Overall, MCB stock has shown consistent growth in total revenue, net income, and EPS over the past year. Investors may find MCB stock to be a promising investment opportunity based on its strong financial performance.

[stock_market_chart symbol=”MCB” range=”3mo” interval=”1d” settings='{“primaryChartType”:”smoothedLine”,”secondaryChartType”:”column”,”width”:”100%”,”height”:”500px”,”marginTop”:0,”marginBottom”:0,”marginLeft”:10,”marginRight”:10,”primaryPanelTitle”:”Price”,”secondaryPanelTitle”:”Volume”,”fontSize”:14,”color”:”#383838″,”primaryLineColor”:”#5679ff”,”primaryLineColorAlpha”:0.15,”secondaryLineColor”:”#5679ff”,”secondaryLineColorAlpha”:0.15,”backgroundColor”:”#fff”,”gridColor”:”#e0e0e0″,”gridAlpha”:0.8,”cursorColor”:”#020202″,”cursorAlpha”:0.8,”scrollbarBackgroundColor”:”#e8e8e8″,”scrollbarSelectedBackgroundColor”:”#f7f7f7″,”scrollbarGraphFillColor”:”#435dc2″,”scrollbarSelectedGraphFillColor”:”#92a8fc”,”primaryLineThickness”:2,”secondaryLineThickness”:1,”gridThickness”:1,”precision”:2,”thousandsSeparator”:”,”,”decimalSeparator”:”.”,”usePrefixes”:false,”searchMode”:”search”,”mouseWheelZoomEnabled”:false,”cursorEnabled”:true,”exportEnabled”:true,”scrollbarEnabled”:true,”legendEnabled”:true,”periods”:”1D,1M,YTD,ALL”,”defaultPeriod”:”1M”}’]

Tags: MCB
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
CTVA stock news

Entegris Provides Earnings Guidance for Q1 FY 2024

Food Producers Stock Market Today

Plantify Foods Expands Partnership in Israel with New Retailer

Finances (2)

Analysts Provide Mixed Ratings and Price Targets for Pactiv Evergreen

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com